NDANASALAEROSOL, METERED
Approved
Jul 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
18
Data completeness
3/8 — Basic
NASACORT (triamcinolone acetonide) by Sanofi is corticosteroid hormone receptor agonists [moa]. First approved in 1991.
Drug data last refreshed 6h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NASACORT is a metered-dose nasal aerosol containing triamcinolone acetonide, a corticosteroid that reduces inflammation by activating glucocorticoid receptors. It is indicated for allergic rhinitis and provides symptomatic relief by suppressing the immune response in nasal tissues.
LOE Approaching
As an LOE-approaching product with moderate competitive pressure (30/100), the NASACORT team is likely in optimization and lifecycle extension mode rather than growth expansion.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (18)
Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers
Started Oct 2020
40 enrolled
Drug-Drug Interaction
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
Started Mar 2018
325 enrolled
Macular EdemaRetinal Vein Occlusion
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
Started Jan 2017
460 enrolled
Macular EdemaRetinal Vein Occlusion
A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)
Started Nov 2016
260 enrolled
Rhinitis Allergic
Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema
Started Nov 2015
0UveitisCystoid Macular Edema
Worked on NASACORT at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.